Search - tctmd.com

Displaying 21 - 40 of 83

Sort: Relevancy | Date

Presentation TCT 2024

TCT 10: Interference of Fentanyl in the Pharmacodynamics and Pharmacokinetics of Ticagrelor: A Meta-Analysis of Randomized Trials

Presenter: BERNARDO KREMER

October 27, 2024

Presentation TCT 2024

TCT 289: Different Efficacy of 12-Month Dual Antiplatelet Therapy Following Off-Pump Versus On-Pump Coronary Artery Bypass Grafting

Presenter: Woo Jin Jang

October 27, 2024

Presentation TCT 2024

TCT 228: Treatment Modifications in Ticagrelor-Treated Patients: Insights From the FORCE-ACS Registry

Presenter: Niels van der Sangen

October 27, 2024

Presentation TCT 2024

TCT 401: Impact of >12-Month Versus =12-Month Dual Antiplatelet Therapy on Long-Term Outcomes After Chronic Total Occlusion Percutaneous Coronary Intervention

Presenter: Yao Jiang

October 27, 2024

Presentation TCT 2024

TCT 286: Impact of Dual Antiplatelet Therapy on Secondary Revascularization due to Native Vessel Disease Progression v/s Graft Failure After Coronary Artery Bypass Graft

Presenter: IFTIKHAR CH

October 27, 2024

Presentation TCT 2024

Antiplatelet Therapy and All-Cause Mortality After Transcatheter Aortic Valve Replacement: The TRITAVI Registry

Presenter: Francesco Pelliccia

October 27, 2024

Presentation TCT 2024

TCT 230: Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk: A Post-Hoc Analysis of the TWILIGHT Trial

Presenter: Mauro Gitto

October 27, 2024

Presentation TCT 2024

TCT 229: Rebound Phenomenon of Platelet Reactivity After Cessation of Long-term Clopidogrel Therapy

Presenter: Jung-Kyu Han

October 27, 2024

Presentation TCT 2024

TCT 231: Safety of Aspirin-Free Prasugrel Monotherapy After PCI: Pooled Analysis of Three Months Outcomes in 508 Patients From ASET-I and ASET-Japan Trials

Presenter: KOTARO MIYASHITA

October 27, 2024

Presentation TCT 2024

TCT 227: Timing and Indications for Cangrelor Use and Transition Modalities to Oral P2Y12 Inhibitors in Patients Undergoing PCI: Insights From the SMILE Study

Presenter: Angelo Oliva

October 27, 2024

Presentation TCT 2024

TCT 4: Rationale and Design of the IMODERN STOP-IMH Randomized Trial: The Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for STEMI and the Effect on Intramyocardial Haemorrhage

Presenter: Bahram Yosofi

October 27, 2024

Presentation TCT 2024

TCT 1: Differential Outcomes in ST-Elevation and Non-ST Elevation Myocardial Infarction Outcomes After Percutaneous Coronary Intervention With Versus Without Cangrelor

Presenter: Andrew Hill

October 27, 2024

Presentation TCT 2024

TCT 5: Safety and Efficacy of Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction: A Meta-Analysis of RCTs

Presenter: Sheref Elseidy

October 27, 2024

Presentation TCT 2024

TCT 3: Ticagrelor Monotherapy After Coronary Stenting in Patients With Acute Myocardial Infarction (TIMO-AMI Study)

Presenter: Oskar Angerås

October 27, 2024

Presentation TCT 2024

TCT 2: Less Bleeding by Omitting Aspirin in Non-ST-Segment Elevation Acute Coronary Syndrome Patients (LEGACY)

Presenter: Shabiga Sivanesan

October 27, 2024

Presentation TCT 2024

TCT 6: Aspirin-Free Prasugrel Monotherapy After PCI in Patients With Non-ST Elevation Acute Coronary Syndrome

Presenter: KOTARO MIYASHITA

October 27, 2024

Presentation TCT 2024

TCT 238: Safety and Efficacy of Cangrelor: A Multicenter Nationwide Registry ARECA (Austrian Registry for Cangrelor Application)

Presenter: Guy Friedrich

October 27, 2024

Presentation TCT 2024

TCT 234: Sex Differences in the Safety and Efficacy of Short-term DAPT Versus DAPT De-escalation After Percutaneous Coronary Intervention

Presenter: Donna Lin

October 27, 2024

Presentation TCT 2024

TCT 237: Long-Term Clopidogrel vs Aspirin Monotherapy in Stable Coronary Artery Disease Patients With High Ischemic Risk: A Post Hoc Analysis of the HOST-EXAM Extended Study

Presenter: Jeehoon Kang

October 27, 2024

Presentation TCT 2024

TCT 236: Bailout Use of Cangrelor During Percutaneous Coronary Intervention and Associated Inpatient Outcomes

Presenter: Abhishek Chaturvedi

October 27, 2024

Advertisement

TCT 10: Interference of Fentanyl in the Pharmacodynamics and Pharmacokinetics of Ticagrelor: A Meta-Analysis of Randomized Trials

TCT 289: Different Efficacy of 12-Month Dual Antiplatelet Therapy Following Off-Pump Versus On-Pump Coronary Artery Bypass Grafting

TCT 228: Treatment Modifications in Ticagrelor-Treated Patients: Insights From the FORCE-ACS Registry

TCT 401: Impact of >12-Month Versus =12-Month Dual Antiplatelet Therapy on Long-Term Outcomes After Chronic Total Occlusion Percutaneous Coronary Intervention

TCT 286: Impact of Dual Antiplatelet Therapy on Secondary Revascularization due to Native Vessel Disease Progression v/s Graft Failure After Coronary Artery Bypass Graft

Antiplatelet Therapy and All-Cause Mortality After Transcatheter Aortic Valve Replacement: The TRITAVI Registry

TCT 230: Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk: A Post-Hoc Analysis of the TWILIGHT Trial

TCT 229: Rebound Phenomenon of Platelet Reactivity After Cessation of Long-term Clopidogrel Therapy

TCT 231: Safety of Aspirin-Free Prasugrel Monotherapy After PCI: Pooled Analysis of Three Months Outcomes in 508 Patients From ASET-I and ASET-Japan Trials

TCT 227: Timing and Indications for Cangrelor Use and Transition Modalities to Oral P2Y12 Inhibitors in Patients Undergoing PCI: Insights From the SMILE Study

TCT 4: Rationale and Design of the IMODERN STOP-IMH Randomized Trial: The Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for STEMI and the Effect on Intramyocardial Haemorrhage

TCT 1: Differential Outcomes in ST-Elevation and Non-ST Elevation Myocardial Infarction Outcomes After Percutaneous Coronary Intervention With Versus Without Cangrelor

TCT 5: Safety and Efficacy of Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction: A Meta-Analysis of RCTs

TCT 3: Ticagrelor Monotherapy After Coronary Stenting in Patients With Acute Myocardial Infarction (TIMO-AMI Study)

TCT 2: Less Bleeding by Omitting Aspirin in Non-ST-Segment Elevation Acute Coronary Syndrome Patients (LEGACY)

TCT 6: Aspirin-Free Prasugrel Monotherapy After PCI in Patients With Non-ST Elevation Acute Coronary Syndrome

TCT 238: Safety and Efficacy of Cangrelor: A Multicenter Nationwide Registry ARECA (Austrian Registry for Cangrelor Application)

TCT 234: Sex Differences in the Safety and Efficacy of Short-term DAPT Versus DAPT De-escalation After Percutaneous Coronary Intervention

TCT 237: Long-Term Clopidogrel vs Aspirin Monotherapy in Stable Coronary Artery Disease Patients With High Ischemic Risk: A Post Hoc Analysis of the HOST-EXAM Extended Study

TCT 236: Bailout Use of Cangrelor During Percutaneous Coronary Intervention and Associated Inpatient Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content